Immunomodulation therapy with lenalidomide in follicular, transformed and diffuse large B cell lymphoma: current data on safety and efficacy

Lenalidomide is an immunomodulatory agent which has been approved for multiple myeloma. Lenalidomide is also effective in and tolerated well by patients with follicular lymphoma, diffuse large B-cell lymphoma, and transformed large cell lymphoma. This review summarizes the results of current preclin...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Madhav, Newberry, Kate J, Romaguera, Jorge, Zhang, Liang, Ou, Zhishuo, Wang, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735404/
https://www.ncbi.nlm.nih.gov/pubmed/23915913
http://dx.doi.org/10.1186/1756-8722-6-55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735404/
https://www.ncbi.nlm.nih.gov/pubmed/23915913
http://dx.doi.org/10.1186/1756-8722-6-55

Ejemplares similares